• Company Name : Ilyang Pharmaceuticals Co Ltd
  • About Us : Company OverviewFounded in 1946, Ilyang pharmaceutical is one of the leading Korean pharmaceutical companies that focus on developing new chemical entities (NCEs). It Commensurate with its long experience, Ilyang pharmaceutical company has been kept its great reputation trying to unburden patients hardships. In 2010, Ilyang pharm has proudly launched its NME for PPI, Noltec (Ilaprazole 10mg), having indications on GU, DU, and GERD. ILYANG s other core business are Chronic Myeloginious Leukemia (CML) and Vaccine. The multinational phase II study of IY5511 for the treatment of CML will be completed shortly. Ilyang Pharmaceuticals Co Ltd have begun constructing new vaccine factory that is expected to produce 60 million doses of influenza vaccine as well. Ilyang has nearly 730 employees in Korea and about 2,000 employees worldwide, focusing on development of small molecule in the field of GI, Oncology, and dermatology.
  • Product/Service : Influenza vaccine,Vaccines,Pentavalent, Td, Bio
  • Country/Region : South Korea >
  • Category : Health & Medical
  • Contact Person : Mr. E Abbas
  • Link More : South Korea Health & Medical ,South Korea Health Food
  • Telephone :
  • Address : Ilayng Building, 544-5, Dpgok-dong, Gangnam-gu
  • Website : www.ilyang.co.kr
  • Business Type : Manufacturer, Distributor/Wholesaler